How Will Healthcare M&A Change Under the Trump Administration?

The healthcare M&A market continues to be among the most active sectors. In 2016, there were 939 healthcare industry deals in the U.S. with an aggregate value of approximately $71.7 billion.

How will policies and goals of the new administration likely impact healthcare M&A trends? How will changes in the regulatory landscape affect M&A across all healthcare stakeholder segments? What can you expect to see in terms of antitrust regulation and enforcement? Manatt addresses these and other key questions in a new webinar for Bloomberg BNA.

The session will:

  • Share an up-to-the-minute look at the status of ACA repeal and replace/repair efforts in Congress and the Executive Branch—and the implications of various scenarios on the healthcare sector.
  • Analyze the conflicting policy goals and political dynamics driving the debate around the ACA.
  • Review the changing landscape, critical issues and key takeaways for payer transactions in the wake of the failed insurance mega-mergers.
  • Examine hospital M&A and antitrust trends, including how the current climate might affect hospital transactions.
  • Explore the issues around forming and operating Accountable Care Organizations (ACOs).
  • Reveal the latest trends in state-action antitrust immunity for healthcare transactions.
  • Anticipate how healthcare antitrust enforcement may change with a new administration.
  • Present an update on regulatory and private antitrust activity in pharmaceutical pricing and pay-for-delay settlements.

If you would like to receive an audio transcript of this webinar due to accessibility issues, please email us at

This program does not constitute legal advice, nor does it establish an attorney-client relationship. Views expressed by presenters are strictly their own and should not be construed to be the views of Manatt or attributed to Manatt.



pursuant to New York DR 2-101(f)

© 2024 Manatt, Phelps & Phillips, LLP.

All rights reserved